Oncolytic Virus Therapy Market

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn?t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Oncolytic Virus Therapy Market contains market size and forecasts of Oncolytic Virus Therapy in Global, including the following market information:
Global Oncolytic Virus Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Oncolytic Virus Therapy market was valued at 6 million in 2021 and is projected to reach US$ 28 million by 2028, at a CAGR of 23.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
HSV-based Oncolytic Viruses Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oncolytic Virus Therapy include Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics and Sorrento Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Oncolytic Virus Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncolytic Virus Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Oncolytic Virus Therapy Market Segment Percentages, by Type, 2021 (%)
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
Global Oncolytic Virus Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Oncolytic Virus Therapy Market Segment Percentages, by Application, 2021 (%)
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
Global Oncolytic Virus Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Oncolytic Virus Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncolytic Virus Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Oncolytic Virus Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys